The voice for the millions of colorectal/bowel cancer patients worldwide. Advocating for increased awareness, screening, & access to quality medical treatment.
In Tanzania, 90% of colorectal cancer patients are diagnosed at advanced stages. @oncointelligenc e's Tumbo Fresh Campaign reached 2,600 people, screened 141, distributed 110 colostomy care packages, and trained 40 youth advocates in 5 weeks. Health equity in action. Read more: gcca.info/Blog_Post_6_12_26_β¦
Our CEO, @AndrewRSpiegel , will be at @WHO Academy in Lyon for the "Simulation for global health: from innovation to implementation" event, bringing evidence-based simulation into health workforce training. Organized with @SESAMSimulation .
Learn more: gcca.info/CRC_News_6_12_26_X
π GCCA MONTH Member Meeting βJune 17 at 8am UTC. Topic: Patient and Public Involvement and Engagement (PPIE). Speaker: Stephen Rowley of Bowel Matters Cancer Support. #GCCA#ColorectalCancer@
𧬠Know Your Biomarker: c-MET
MET is a gene that produces the c-MET protein, which helps regulate cell growth and movement. When abnormal, it may contribute to colorectal cancer growth and spread.
All patients with stage IV #ColorectalCancer should ask about biomarker testing, including c-MET.
Download the full guide: gcca.info/KYB_CMET_X#CRC#PrecisionMedicine#Biomarkers#MetastaticCRC
π Registration is OPEN for the 2026 Global CRC Congress!
Join us Nov. 5β6 as patient advocates, healthcare professionals, policymakers, researchers, and industry leaders come together to learn, connect, and drive action on:
β Screening & Prevention
β Biomarkers & Precision Medicine
β Treatment Innovation
β Equity & Access
β Advocacy & Policy
π Nov. 5β6, 2026
π» Hybrid Event
Register today and join the global conversation on the future of colorectal cancer care.
gcca.info/X_Congress_26#GlobalCRCCongress#CRCAdvocacy#ColorectalCancer
A major win for #PrecisionMedicine.
Daraxonrasib significantly improved outcomes in metastatic pancreatic cancer, marking an important breakthrough against RAS-driven tumors.
Why it matters for #ColorectalCancer: RAS mutations occur in 40-50% of CRC cases, and this success could help accelerate progress across RAS-targeted therapies.
#KnowYourBiomarker#RASolute
π¨ Nominations are now open for the Global CRC Leadership Awards.
Weβre recognizing leaders in policy & advocacy, equity & community engagement, and emerging leadership in colorectal cancer.
Nominate someone making a difference --> gcca.info/Leadership_awards_β¦
Deadline: July 15 Β· No GCCA membership required
#GCCAawards#ColorectalCancer
Something is coming for Colorectal Cancer Awareness Month 2027.
We've been working behind the scenes on a new global initiative and we can't wait to share it with you.
Not yet. π
Stay tuned.
#CRC#ColorectalCancer#ComingSoon
More options. More people screened. More lives saved.
GCCA welcomes the updated @AmericanCancer Society colorectal cancer screening guidelines, which add new blood-based and at-home screening options.
We agree: the best screening test is the one people do. Expanding choice can help close screening gaps and save lives. #CRC#ColorectalCancer#CancerScreening
FAP is a hereditary syndrome. Nearly 100% lifetime CRC risk if untreated.
Dan had a routine colonoscopy at 50. Hundreds of polyps. Genetic testing confirmed attenuated FAP. He chose preventive surgery. 13 years later, cancer-free.
20 polyps? Ask about FAP testing.
Read Dan's full story: gcca.info/KIWTW_X_Dan#KnowingIsWorthTheWait#FAP#ColorectalCancer#ASCO26
5 questions worth asking your oncologist about clinical trials:
β Are there any trials appropriate for me?
β How does a trial fit into my treatment?
β What are the benefits and risks?
β What costs are covered?
β Can I leave if I change my mind?
Free guide: gcca.info/CTA_X_Questions#TrialTalk#ColorectalCancer
Many oncologists won't raise the subject of clinical trials unless you ask. Most patients don't know they can.
This guide from @GlobalCRC helps close that gap.
#TrialTalk
Source: @CDCgov confirms the HPV vaccine protects against anal cancer 5 other cancer types β cdc.gov/cancer/hpv
And the May 14, 1796 date? Documented by @WHO and peer-reviewed at PMC1200696.
230 years of science. Still working. π